Health Condition 1: G439- Migraine, unspecified
Conditions
Interventions
Intervention1: Individualized homoeopathic medicines in individualized dosage and concomitant care: The enrolled patients of migraine will be treated with IHMs selected using Boenninghausenâ??s hexame
dosage 11
and repetition
will be given depending upon the individual case requirement. Similar to the experimental arm, management directions will be provided. Concomitant care measures include lifest
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of age group 18-50 years. 2. Either sex or transgender. 3. Patients having migraine (ICD 10 code G43) as per the criteria of International Classification of Headache Disorders (ICHD-3) for migraine. I. Migraine with aura a. Headache attacks lasting 4 to 72 hours (untreated or unsuccessfully treated) b. Headache has at least 2 of the following characteristics: i. Unilateral location ii. Pulsating quality iii. Moderate-to-severe pain intensity iv. Aggravation by or causing avoidance of routine physical activity (walking or climbing stairs) c. During a headache, at least 1 of the following: i. Nausea and/or vomiting ii. Photophobia and phonophobia II. Migraine with aura a. 1 or more of the fully reversible aura symptoms mentioned below: i. Visual ii. Sensory iii. Speech and language iv. Motor v. Brainstem vi. Retinal b. At least 2 of the characteristics mentioned below: i. At least 1 aura symptom spreads gradually over 5 or more minutes ii. 2 or more aura symptoms occur in succession iii. Each aura symptom lasts 5 to 60 minutes iv. At least 1 aura symptom is unilateral v. At least 1 aura symptom is positive vi. The aura is accompanied, or followed within 60 minutes, by the headache III. On 8 days or more per month for more than 3 months, fulfilling any of the below mentioned criteria: 9 a. Criteria Ib and Ic: For migraine without aura b. Criteria IIa and IIb: For migraine with aura c. Believed by the patient to be migraine headaches at onset and relieved by triptan or ergot derivative 4. Patients with ability to understand English/ Hindi/ Bengali.
Exclusion criteria
Exclusion criteria: 1. Denying informed consent. 2. Patient suffering from little or no disability (MIDAS Score less than or equal to 20) and severe disability (MIDAS Score more than or equal to 20) from migraine. 3. An acute, severe headache, particularly if it is the first or worst episode and there has been a noticeable shift in the frequency or pattern of headaches. 4. Abnormal neurologic examination, particularly in cases when there are unidentified indications or symptoms (e.g., stiff neck, confusion, papilledema, epilepsy). 5. New episodes in immunocompromised or elderly patients (more than 50 years of age).. 6. Signs or symptoms that are meningeal or systemic e.g. fever, weight loss, exhaustion. 7. Pain that lasts longer than 72 hours. 8. Pregnancy, nursing mothers, and puerperal women. 9. Chewing tobacco, smoking, alcoholism, substance misuse in any form, and/or dependence (TAPS tool). 10. Receiving homoeopathic treatment for a chronic illness all through the previous three months. 11. Simultaneously taking part in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Migraine Disability Assessment questionnaire (MIDAS)Timepoint: Baseline and after 3rd month | — |
Secondary
| Measure | Time frame |
|---|---|
| 36-Item Short Form Health Survey questionnaire (SF-36)Timepoint: Baseline and every month up to 3 months;Measures Yourself Medical Outcome Profile version 2 questionnaire (MYMOP-2)Timepoint: Baseline and every month up to 3 months | — |
Countries
India
Contacts
Public ContactRajat Kumar Pal
D n De Homoeopathic Medical College and Hospital
Outcome results
None listed